Welcome to our dedicated page for ARGAN SEC filings (Ticker: AGX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Argan, Inc. SEC filings document the company’s operating results, material events and governance as a NYSE-listed construction services issuer. Recent 8-K filings report quarterly and fiscal financial results, cash dividends, share repurchase program actions, and engineering, procurement and construction contract developments involving Gemma Power Systems and power-generation projects.
Proxy materials cover board elections, executive compensation, equity awards, shareholder voting matters and related governance disclosures. The filings also identify Argan’s common stock registration and formal event reporting for capital allocation and project-backlog developments.
James W. Quinn, Director of Argan (NYSE: AGX), received a new grant of 530 Time-Based Restricted Stock Units (TRSUs) on June 17, 2025. This equity compensation award represents part of the director's compensation package.
Key details of the transaction:
- The TRSUs have a $0 exercise price
- Full vesting is scheduled for April 17, 2026
- Each TRSU converts to one share of common stock
- Following this grant, Quinn beneficially owns 3,947 TRSUs directly
The filing was reported through Form 4 on June 20, 2025, within the required reporting window for insider transactions. Quinn serves as a non-employee director and is not a 10% owner of the company. The grant appears to be part of the company's standard director compensation program.
Form 4 filing overview: On June 17, 2025, Argan, Inc. (AGX) director John R. Jeffrey Jr. was granted 530 time-based restricted stock units (RSUs) at a conversion price of $0. The RSUs will vest in full on April 17, 2026.
After the grant, the director’s aggregate derivative holdings tied to AGX common stock increased to 3,947 RSUs. No common shares were bought or sold on the open market, so the transaction has no direct cash impact on the company. This appears to be a routine equity-compensation award intended to further align the director’s incentives with shareholder interests.
Argan, Inc. (AGX) – Form 4 insider filing:
Director Lisa Larroque filed a Form 4 on 20 June 2025 disclosing the award of 530 Time-Based Restricted Stock Units (TRSUs) granted on 17 June 2025. Each TRSU converts into one share of AGX common stock at no cost and will vest fully on 17 April 2026.
The filing shows no open-market purchases or sales; it is strictly an equity incentive grant. Following the transaction, the director’s derivative holdings linked to common stock increased to 1,225 units, all held directly.
The award is part of routine director compensation, adds only a modest potential dilution upon settlement, and does not alter Argan’s capital structure or control.